ELOCTATE 500

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

COAGULATION FACTOR VIII

제공처:

SANOFI - AVENTIS ISRAEL LTD

ATC 코드:

B02BD05

약제 형태:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

구성:

COAGULATION FACTOR VIII 500 IU

관리 경로:

I.V

처방전 유형:

Required

Manufactured by:

BIOGEN IDEC LIMITED , UK

치료 영역:

COAGULATION FACTOR VII

치료 징후:

ELOCTATE [Antihemophilic Factor (Recombinant Fc Fusion Protein)] is a long-acting antihemophilic factor (recombinant) indicated in adults and children 12 years of age and older with Hemophilia A (congenital factor VIII deficiency) for:• Control and prevention of bleeding episodes.• Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.• Perioperative management (surgical prophylaxis).ELOCTATE is not indicated for the treatment of von Willebrand disease.

승인 날짜:

2017-01-09